BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
MacroGenics
MGNX
$273M
| $58.4K | ﹤0.01% |
2,176
-4,844
| -69% | -$142K |
|
3077
Caesarstone
CSTE
$110M
| $58.4K | ﹤0.01% |
3,959
-7,287
| -65% | -$110K |
|
3078
AXT Inc
AXTI
$5.07B
| $58.4K | ﹤0.01% |
5,319
-13,559
| -72% | -$144K |
|
|
BRY
3079
DELISTED
Berry Corp
BRY
| $58.4K | ﹤0.01% |
8,685
-25,134
| -74% | -$159K |
|
3080
CALL
BHP
BHP
$223B
| $58.3K | ﹤0.01% |
9
-168
| -95% | -$11.1K |
|
|
RRD
3081
DELISTED
RR Donnelley & Sons Co.
RRD
| $58.1K | ﹤0.01% |
+9,250
| New | +$50.4K |
|
|
RJET
3082
Republic Airways Holdings
RJET
$957M
| $57.5K | ﹤0.01% |
411
-696
| -63% | -$112K |
|
|
PRVB
3083
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $57.4K | ﹤0.01% |
6,814
-35
| -0.5% | -$282 |
|
|
GOLD
3084
Gold.com Inc
GOLD
$1.28B
| $57.3K | ﹤0.01% |
2,466
-2,194
| -47% | -$49K |
|
3085
PUT
Altria Group
MO
$110B
| $57.2K | ﹤0.01% |
12
| – | – |
|
|
ALSK
3086
DELISTED
Alaska Communications Systems
ALSK
| $57.2K | ﹤0.01% |
17,178
-8,788
| -34% | -$29.1K |
|
3087
Q32 Bio
QTTB
$465M
| $57.2K | ﹤0.01% |
437
+192
| +78% | +$24K |
|
3088
Malibu Boats
MBUU
$578M
| $56.9K | ﹤0.01% |
776
-2,117
| -73% | -$168K |
|
3089
Nature's Sunshine
NATR
$276M
| $56.8K | ﹤0.01% |
3,270
-2,140
| -40% | -$42.3K |
|
|
TCRR
3090
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $56.7K | ﹤0.01% |
3,456
-19,808
| -85% | -$400K |
|
3091
MeiraGTx Holdings
MGTX
$1.27B
| $56.6K | ﹤0.01% |
3,653
+244
| +7% | +$3.49K |
|
|
VRS
3092
DELISTED
Verso Corporation
VRS
| $56.4K | ﹤0.01% |
3,188
-11,030
| -78% | -$182K |
|
3093
nLIGHT
LASR
$3B
| $56.3K | ﹤0.01% |
1,553
-3,068
| -66% | -$91.6K |
|
|
ORC
3094
Orchid Island Capital
ORC
$1.33B
| $55K | ﹤0.01% |
2,121
-6,145
| -74% | -$171K |
|
3095
Spok Holdings
SPOK
$228M
| $54.7K | ﹤0.01% |
5,684
-3,496
| -38% | -$37.3K |
|
|
RBNC
3096
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $54.5K | ﹤0.01% |
1,966
-4,858
| -71% | -$139K |
|
3097
Business First Bancshares
BFST
$1.05B
| $54.5K | ﹤0.01% |
2,373
-6,630
| -74% | -$157K |
|
3098
CNB Financial Corp
CCNE
$1.04B
| $54.4K | ﹤0.01% |
2,383
-4,833
| -67% | -$118K |
|
3099
Daily Journal
DJCO
$779M
| $54.2K | ﹤0.01% |
160
-74
| -32% | -$23.8K |
|
|
EB
3100
DELISTED
Eventbrite
EB
| $53.9K | ﹤0.01% |
2,835
-6,057
| -68% | -$128K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.